• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种抗聚乙二醇抗体的结构揭示了一个能够捕获高度灵活的聚乙二醇聚合物的开放环。

Structure of an anti-PEG antibody reveals an open ring that captures highly flexible PEG polymers.

作者信息

Huckaby Justin T, Jacobs Tim M, Li Zhongbo, Perna Robert J, Wang Anting, Nicely Nathan I, Lai Samuel K

机构信息

UNC/NCSU Joint Department of Biomedical Engineering, School of Medicine, University of North Carolina-Chapel Hill, Chapel Hill, NC, 27599, USA.

Division of Pharmacoengineering and Molecular Pharmaceutics, Eshelman School of Pharmacy, University of North Carolina-Chapel Hill, Chapel Hill, NC, 27599, USA.

出版信息

Commun Chem. 2020 Sep 8;3(1):124. doi: 10.1038/s42004-020-00369-y.

DOI:10.1038/s42004-020-00369-y
PMID:36703348
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9814744/
Abstract

Polyethylene glycol (PEG) is a polymer routinely used to modify biologics and nanoparticles to prolong blood circulation and reduce immunogenicity of the underlying therapeutic. However, several PEGylated therapeutics induce the development of anti-PEG antibodies (APA), leading to reduced efficacy and increased adverse events. Given the highly flexible structure of PEG, how APA specifically bind PEG remains poorly understood. Here, we report a crystal structure illustrating the structural properties and conformation of the APA 6-3 Fab bound to the backbone of PEG. The structure reveals an open ring-like sub-structure in the Fab paratope, whereby PEG backbone is captured and then stabilized via Van der Waals interactions along the interior and exterior of the ring paratope surface. Our finding illustrates a strategy by which antibodies can bind highly flexible repeated structures that lack fixed conformations, such as polymers. This also substantially advances our understanding of the humoral immune response generated against PEG.

摘要

聚乙二醇(PEG)是一种常用于修饰生物制剂和纳米颗粒的聚合物,目的是延长血液循环时间并降低潜在治疗药物的免疫原性。然而,几种聚乙二醇化治疗药物会诱导抗聚乙二醇抗体(APA)的产生,导致疗效降低和不良事件增加。鉴于聚乙二醇高度灵活的结构,APA如何特异性结合聚乙二醇仍知之甚少。在此,我们报告了一种晶体结构,展示了与聚乙二醇主链结合的APA 6-3 Fab的结构特性和构象。该结构揭示了Fab互补决定区中一个开放的环状子结构,通过该结构,聚乙二醇主链被捕获,然后沿着环状互补决定区表面的内部和外部通过范德华相互作用得以稳定。我们的发现阐明了一种抗体能够结合缺乏固定构象的高度灵活的重复结构(如聚合物)的策略。这也极大地推进了我们对针对聚乙二醇产生的体液免疫反应的理解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2333/9814744/bc3c865f7072/42004_2020_369_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2333/9814744/598b895edcba/42004_2020_369_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2333/9814744/a9b802c96d79/42004_2020_369_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2333/9814744/c19a3fae454c/42004_2020_369_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2333/9814744/bc3c865f7072/42004_2020_369_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2333/9814744/598b895edcba/42004_2020_369_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2333/9814744/a9b802c96d79/42004_2020_369_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2333/9814744/c19a3fae454c/42004_2020_369_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2333/9814744/bc3c865f7072/42004_2020_369_Fig4_HTML.jpg

相似文献

1
Structure of an anti-PEG antibody reveals an open ring that captures highly flexible PEG polymers.一种抗聚乙二醇抗体的结构揭示了一个能够捕获高度灵活的聚乙二醇聚合物的开放环。
Commun Chem. 2020 Sep 8;3(1):124. doi: 10.1038/s42004-020-00369-y.
2
Pegloticase co-administered with high MW polyethylene glycol effectively reduces PEG-immunogenicity and restores prolonged circulation in mouse.培戈洛酶与高分子量聚乙二醇联合给药可有效降低 PEG 的免疫原性,并恢复其在小鼠体内的长效循环。
Acta Biomater. 2023 Oct 15;170:250-259. doi: 10.1016/j.actbio.2023.08.052. Epub 2023 Aug 31.
3
Cross-Reactivity of Select PEG-Binding Antibodies to Other Polymers Containing a C-C-O Backbone.某些聚乙二醇结合抗体与其他含C-C-O主链聚合物的交叉反应性。
ACS Biomater Sci Eng. 2017 Aug 14;3(8):1605-1615. doi: 10.1021/acsbiomaterials.7b00147. Epub 2017 Jun 22.
4
Polyethylene Glycol Immunogenicity: Theoretical, Clinical, and Practical Aspects of Anti-Polyethylene Glycol Antibodies.聚乙二醇免疫原性:抗聚乙二醇抗体的理论、临床和实际问题。
ACS Nano. 2021 Sep 28;15(9):14022-14048. doi: 10.1021/acsnano.1c05922. Epub 2021 Sep 1.
5
Pre-treatment with high molecular weight free PEG effectively suppresses anti-PEG antibody induction by PEG-liposomes in mice.预处理用高分子量游离 PEG 可有效抑制 PEG-脂质体在小鼠体内诱导抗 PEG 抗体。
J Control Release. 2021 Jan 10;329:774-781. doi: 10.1016/j.jconrel.2020.10.011. Epub 2020 Oct 7.
6
Anti-PEG antibodies alter the mobility and biodistribution of densely PEGylated nanoparticles in mucus.抗聚乙二醇抗体可改变高度聚乙二醇化纳米颗粒在黏液中的迁移率和生物分布。
Acta Biomater. 2016 Oct 1;43:61-70. doi: 10.1016/j.actbio.2016.07.019. Epub 2016 Jul 14.
7
A minimal physiologically based pharmacokinetic model that predicts anti-PEG IgG-mediated clearance of PEGylated drugs in human and mouse.一个最小生理药代动力学模型,可预测人及鼠体内聚乙二醇化药物的抗聚乙二醇 IgG 介导清除率。
J Control Release. 2018 Aug 28;284:171-178. doi: 10.1016/j.jconrel.2018.06.002. Epub 2018 Jun 5.
8
A double antigen bridging immunogenicity ELISA for the detection of antibodies to polyethylene glycol polymers.一种用于检测聚乙二醇聚合物抗体的双抗原桥联免疫原性酶联免疫吸附测定法。
J Pharmacol Toxicol Methods. 2011 Nov-Dec;64(3):238-45. doi: 10.1016/j.vascn.2011.07.003. Epub 2011 Jul 29.
9
PEG-Like Brush Polymer Conjugate of RNA Aptamer That Shows Reversible Anticoagulant Activity and Minimal Immune Response.具有可逆抗凝活性和最小免疫反应的RNA适配体的聚乙二醇样刷状聚合物缀合物。
Adv Mater. 2022 Mar;34(10):e2107852. doi: 10.1002/adma.202107852. Epub 2022 Jan 31.
10
Accelerated clearance by antibodies against methoxy PEG depends on pegylation architecture.针对甲氧基聚乙二醇的抗体加速清除取决于聚乙二醇化结构。
J Control Release. 2023 Feb;354:354-367. doi: 10.1016/j.jconrel.2023.01.021. Epub 2023 Jan 17.

引用本文的文献

1
Considering the immunogenicity of PEG: strategies for overcoming issues with PEGylated nanomedicines.考虑到聚乙二醇(PEG)的免疫原性:克服聚乙二醇化纳米药物相关问题的策略。
Nanomedicine (Lond). 2025 Sep;20(18):2375-2391. doi: 10.1080/17435889.2025.2538423. Epub 2025 Jul 29.
2
Isomerization of Poly(ethylene glycol): A Strategy for the Evasion of Anti-PEG Antibody Recognition.聚乙二醇的异构化:一种逃避抗聚乙二醇抗体识别的策略。
J Am Chem Soc. 2025 Jun 25;147(25):21538-21548. doi: 10.1021/jacs.5c02716. Epub 2025 Jun 13.
3
PEGylation technology: addressing concerns, moving forward.

本文引用的文献

1
Cross-Reactivity of Select PEG-Binding Antibodies to Other Polymers Containing a C-C-O Backbone.某些聚乙二醇结合抗体与其他含C-C-O主链聚合物的交叉反应性。
ACS Biomater Sci Eng. 2017 Aug 14;3(8):1605-1615. doi: 10.1021/acsbiomaterials.7b00147. Epub 2017 Jun 22.
2
Structural basis of polyethylene glycol recognition by antibody.抗体识别聚乙二醇的结构基础。
J Biomed Sci. 2020 Jan 7;27(1):12. doi: 10.1186/s12929-019-0589-7.
3
Pretargeted delivery of PEG-coated drug carriers to breast tumors using multivalent, bispecific antibody against polyethylene glycol and HER2.
聚乙二醇化技术:解决问题,向前迈进。
Drug Deliv. 2025 Dec;32(1):2494775. doi: 10.1080/10717544.2025.2494775. Epub 2025 Apr 23.
4
Poly(2-ethyl-2-oxazoline) (POx) as Poly(ethylene glycol) (PEG)-Lipid Substitute for Lipid Nanoparticle Formulations.聚(2-乙基-2-恶唑啉)(POx)作为脂质纳米颗粒制剂的聚乙二醇(PEG)-脂质替代物
Small. 2025 Apr;21(16):e2411354. doi: 10.1002/smll.202411354. Epub 2025 Mar 19.
5
Antigenicity Extension: A Novel Concept Explained by the Immunogenicity of PEG.抗原性扩展:由聚乙二醇免疫原性解释的新概念。
ACS Bio Med Chem Au. 2024 Oct 10;5(1):42-54. doi: 10.1021/acsbiomedchemau.4c00042. eCollection 2025 Feb 19.
6
PEG-mCherry interactions beyond classical macromolecular crowding.聚乙二醇(PEG)与单体红色荧光蛋白(mCherry)的相互作用超越了经典的大分子拥挤效应。
Protein Sci. 2025 Mar;34(3):e5235. doi: 10.1002/pro.5235.
7
pH-Responsive Polyethylene Glycol Engagers for Enhanced Brain Delivery of PEGylated Nanomedicine to Treat Glioblastoma.用于增强聚乙二醇化纳米药物向脑内递送以治疗胶质母细胞瘤的pH响应性聚乙二醇接合体
ACS Nano. 2025 Jan 14;19(1):307-321. doi: 10.1021/acsnano.4c05906. Epub 2025 Jan 3.
8
Context-dependent effect of polyethylene glycol on the structure and dynamics of hirudin.聚乙二醇对水蛭素结构与动力学的上下文依赖性效应
Biophys J. 2025 Jan 7;124(1):192-204. doi: 10.1016/j.bpj.2024.11.3311. Epub 2024 Nov 26.
9
Optimizing Pharmacological and Immunological Properties of Therapeutic Proteins Through PEGylation: Investigating Key Parameters and Their Impact.通过聚乙二醇化优化治疗性蛋白质的药理学和免疫学性质:研究关键参数及其影响。
Drug Des Devel Ther. 2024 Nov 7;18:5041-5062. doi: 10.2147/DDDT.S481420. eCollection 2024.
10
Striving for Uniformity: A Review on Advances and Challenges To Achieve Uniform Polyethylene Glycol.追求一致性:关于实现均匀聚乙二醇的进展与挑战的综述
Org Process Res Dev. 2024 Apr 1;28(4):860-890. doi: 10.1021/acs.oprd.3c00428. eCollection 2024 Apr 19.
利用针对聚乙二醇和 HER2 的多价双特异性抗体将聚乙二醇涂层的药物载体靶向递送至乳腺肿瘤。
Nanomedicine. 2019 Oct;21:102076. doi: 10.1016/j.nano.2019.102076. Epub 2019 Aug 5.
4
Enhanced drug internalization and therapeutic efficacy of PEGylated nanoparticles by one-step formulation with anti-mPEG bispecific antibody in intrinsic drug-resistant breast cancer.通过与内源性耐药乳腺癌中的抗聚乙二醇双特异性抗体一步形成,增强 PEG 化纳米颗粒的药物内化和治疗效果。
Biomater Sci. 2019 Aug 1;7(8):3404-3417. doi: 10.1039/c9bm00323a. Epub 2019 Jun 28.
5
Engineering Polymer-Binding Bispecific Antibodies for Enhanced Pretargeted Delivery of Nanoparticles to Mucus-Covered Epithelium.工程化聚合物结合双特异性抗体以增强纳米颗粒对黏液覆盖上皮的靶向递释。
Angew Chem Int Ed Engl. 2019 Apr 16;58(17):5604-5608. doi: 10.1002/anie.201814665. Epub 2019 Mar 21.
6
Revealing the Immunogenic Risk of Polymers.揭示聚合物的免疫原性风险。
Angew Chem Int Ed Engl. 2018 Oct 15;57(42):13873-13876. doi: 10.1002/anie.201808615. Epub 2018 Sep 19.
7
Bispecific antibodies (anti-mPEG/anti-HER2) for active tumor targeting of docetaxel (DTX)-loaded mPEGylated nanocarriers to enhance the chemotherapeutic efficacy of HER2-overexpressing tumors.载多西紫杉醇(DTX)的 mPEG 化纳米载体的双特异性抗体(抗-mPEG/抗-HER2)主动靶向肿瘤,以增强过表达 HER2 的肿瘤的化疗疗效。
Drug Deliv. 2018 Nov;25(1):1066-1079. doi: 10.1080/10717544.2018.1466936.
8
Structural Basis of Enhanced Crystallizability Induced by a Molecular Chaperone for Antibody Antigen-Binding Fragments.分子伴侣增强抗体抗原结合片段可结晶性的结构基础。
J Mol Biol. 2018 Feb 2;430(3):322-336. doi: 10.1016/j.jmb.2017.12.010. Epub 2017 Dec 22.
9
Conditional internalization of PEGylated nanomedicines by PEG engagers for triple negative breast cancer therapy.通过 PEG 衔接物对 PEG 化纳米药物进行条件内化用于三阴性乳腺癌治疗。
Nat Commun. 2017 Jun 8;8:15507. doi: 10.1038/ncomms15507.
10
Optimization of an Anti-poly(ethylene glycol) (anti-PEG) Cell-Based Capture System To Quantify PEG and PEGylated Molecules.优化抗聚乙二醇(anti-PEG)基于细胞的捕获系统以定量聚乙二醇(PEG)和 PEG 化分子。
Anal Chem. 2016 Dec 20;88(24):12371-12379. doi: 10.1021/acs.analchem.6b03614. Epub 2016 Nov 30.